CMS Resources for COVID-19 Response
Resources
-
CMS Guidance for Insurers on Reimbursement of At-Home COVID-19 Tests
-
CMS Increases Medicare Payment for COVID-19 Monoclonal Antibody Infusions
-
Trump Administration Acts to Ensure Coverage of Life-Saving COVID-19 Vaccines & Therapeutics
-
CMS Clarifies COVID-19 Relief Funds Won’t Penalize Future Medicare Pay
-
CMS Outlines Telehealth Reimbursement for 2020-21 eCQM Programs
-
Trump Administration Encourages Reopening of Healthcare Facilities
-
CMS Relaxing More Value-Based Model Requirements in Wake of Pandemic
-
CMS Increases Medicare Payment for High-Production Coronavirus Lab Tests
- Guidance on Re-opening Health Care Facilities to Provide Non-Emergent Non-COVID Healthcare – Phase 1
- Federal Disaster Resources
- 2021 Medicare Advantage and Part D Rate Announcement Fact Sheet
Updated Guidance for MA and Part D Plan Sponsors
CMS Guidance to Part D Plans Allows Pharmacist Authorization of Emergency Refills When Prescribers Are Unavailable
On Friday, April 3, 2020, CMS issued guidance to Part D plans that the agency will exercise its enforcement discretion to allow pharmacists to authorize emergency refills when prescribers are not available to provide refill renewal prescriptions, when consistent with State emergency declarations.
CMS Update: Coronavirus Waivers and Flexibilities
Medicare Advantage and Part D Plans: CMS Flexibilities to Fight COVID-19
CMS Medicare Part D Preliminary Guidance
Featured News & Resources
See Full CalendarNews & Resources by Topic
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.